» Articles » PMID: 8335364

A Family of Strain-variant Surface Lipoproteins of Mycoplasma Fermentans

Overview
Journal Infect Immun
Date 1993 Aug 1
PMID 8335364
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The wall-less procaryote Mycoplasma fermentans is currently being examined as an agent potentially associated with human disease, including infectious processes affecting immunocompromised individuals. To delineate and understand the interactions of M. fermentans with its host, specific membrane surface components were characterized as markers for detecting the organism and for assessing heterogeneity in antigenic surface architecture within this mycoplasma species. Detergent phase fractionation of metabolically labeled organisms of type strain PG18 identified a family of prominent integral membrane proteins; several of these labeled with 35S-cysteine and 3H-palmitate, which are characteristics of procaryotic lipoproteins. Specific monoclonal and polyclonal antibodies raised to strain PG18 components further distinguished seven of these membrane proteins, which were localized on the organism's surface by monitoring their selective susceptibility during trypsin treatment of intact cells. With these antibodies, Western immunoblot profiles of surface membrane antigens expressed on strain PG18 were compared with those expressed on the recently identified Incognitus strain of M. fermentans, as well as with several other human and animal mycoplasma species. While the antibodies were specific for M. fermentans, marked differences were observed between the strains in the size of one surface lipoprotein and in the apparent levels of several antigens expressed in the cultured populations analyzed. Some monoclonal antibodies to strain PG18 and a previously described monoclonal antibody to strain Incognitus showed apparent selectivity for the strain used for immunization. Monoclonal antibodies developed here recognize stable epitopes defining a family of surface lipoproteins and provide critical tools to determine the basis of surface variation in this mycoplasma species and to assess the location and antigenic phenotypes of organisms in the human host.

Citing Articles

Immune Evasion of : An Overview.

Liu Y, Wang Y, Zheng S Int J Mol Sci. 2024; 25(5).

PMID: 38474071 PMC: 10932453. DOI: 10.3390/ijms25052824.


Mycoplasmal lipid-associated membrane proteins and Mycoplasma arthritidis mitogen recognition by serum antibodies from patients with rheumatoid arthritis.

da Rocha Sobrinho H, Jarach R, Da Silva N, Shio M, Jancar S, Timenetsky J Rheumatol Int. 2010; 31(7):951-7.

PMID: 21052674 DOI: 10.1007/s00296-010-1612-1.


Isolation and partial purification of macrophage- and dendritic cell-activating components from Mycoplasma arthritidis: association with organism virulence and involvement with Toll-like receptor 2.

Cole B, Mu H, Pennock N, Hasebe A, Chan F, Washburn L Infect Immun. 2005; 73(9):6039-47.

PMID: 16113324 PMC: 1231055. DOI: 10.1128/IAI.73.9.6039-6047.2005.


Identification and functional mapping of the Mycoplasma fermentans P29 adhesin.

Leigh S, Wise K Infect Immun. 2002; 70(9):4925-35.

PMID: 12183538 PMC: 128281. DOI: 10.1128/IAI.70.9.4925-4935.2002.


Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans.

Davis K, Wise K Infect Immun. 2002; 70(3):1129-35.

PMID: 11854192 PMC: 127791. DOI: 10.1128/IAI.70.3.1129-1135.2002.


References
1.
Bricker T, Boyer M, Keith J, Wise K . Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis. Infect Immun. 1988; 56(2):295-301. PMC: 259279. DOI: 10.1128/iai.56.2.295-301.1988. View

2.
Wise K, Kim M . Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid. J Bacteriol. 1987; 169(12):5546-55. PMC: 213984. DOI: 10.1128/jb.169.12.5546-5555.1987. View

3.
Lo S, Shih J, Newton 3rd P, Wong D, Hayes M, Benish J . Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. Am J Trop Med Hyg. 1989; 41(5):586-600. DOI: 10.4269/ajtmh.1989.41.586. View

4.
Rosengarten R, Wise K . Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins. Science. 1990; 247(4940):315-8. DOI: 10.1126/science.1688663. View

5.
Kim M, Heidari M, Stull S, McIntosh M, Wise K . Identification and mapping of an immunogenic region of Mycoplasma hyopneumoniae p65 surface lipoprotein expressed in Escherichia coli from a cloned genomic fragment. Infect Immun. 1990; 58(8):2637-43. PMC: 258866. DOI: 10.1128/iai.58.8.2637-2643.1990. View